Call details

ERA PerMed is an ERA-NET Cofund, supported by 32 partners of 23 countries and cofunded by the European Commission (EC). To align national research strategies, promote excellence, reinforce the competitiveness of European players in Personalised Medicine (PM), and enhance the European collaboration with non-EU countries, 31 funding organisations have agreed to launch the third Joint Transnational Call for research projects in PM. This represents the second of three additional calls non-cofunded by the EC. The funding organisations participating in this call particularly wish to promote innovative interdisciplinary collaboration and to encourage translational research proposals. The available budget for this call is 27 Mio € (approx.).

Objectives

The overall objectives of the call are to:

- Support translational research projects in the field of Personalised Medicine;
- Encourage and enable interdisciplinary collaborations towards the implementation of PM, combining pre-clinical and/or clinical research with bioinformatics components and research on relevant ethical, legal and social aspects and/or research on the optimisation of health care systems;
- Encourage collaboration between academia (research teams from universities, higher education institutions, public research institutions), clinical/public health research (research teams from hospital/ public health, health care settings and other health care organisations), private partners e.g. SMEs7 (small and medium-sized enterprises) as well as policy-makers, regulatory/HTA agencies and patient organisations.

Funding Agencies

ISCIII, FCAECC, CDTI, DS-CAT, Gobierno de Navarra

Durada
3 years

More info at http://www.erapermed.eu/joint-calls/joint-transnational-call-2020/

-Only transnational projects will be funded.
-Each consortium submitting a proposal must involve at least three partners eligible for funding coming from three different countries whose funders participate in the call (see list above). All three legal entities must be independent of each other.
-At least two partners of the consortium must be from two different EU Member States or Associated Countries.
-The project coordinator must be eligible to be funded by his/her regional/national participating funding organisation.
-The maximum number of partners per project at the pre-proposal stage is six. At the full-proposal stage, the consortium may be expanded to up to seven partners in total only by inclusion of a partner from an underrepresented country.
-Within one consortium, no more than two partners from the same country participating in the call will be accepted, including those partners with their own funding.
-Partners not eligible for funding by one of the organisations participating in this JTC may participate in projects provided that they demonstrate, with the full-proposal submission, that their economic and human resources have already been secured and will be available at the start of the project.

Joint research proposals may be submitted by applicants belonging to the following categories (subject to regional/national funding regulations; see "Guidelines for Applicants"):

A. Academia (research teams working in universities, other higher education institutions) or research institutes;
B. Clinical/public health sector (research teams working in hospitals/public health and/or other health care settings and health organisations). Participation of clinicians (e.g. medical doctors, nurses) in the research teams is encouraged;
C. (Industry) Private partners, e.g. SMEs15 (small and medium-sized enterprises).

Consortia submitting applications to this call are strongly encouraged to include partners from different categories (A, B and C) in line with the crosscutting/multidisciplinary character of the call, where the aim is to include partners at different levels in the value chain.

For Spanish applicants: please check the eligibility requirements of the institution and the principal investigator/team member